These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10506678)

  • 1. Low-dose subcutaneous ketamine infusion and morphine tolerance.
    Bell RF
    Pain; 1999 Oct; 83(1):101-3. PubMed ID: 10506678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction.
    Akin Takmaz S; Inan N; Günal S; Kaymak C; Sakalli M; Dikmen B
    Agri; 2005 Jul; 17(3):44-7. PubMed ID: 16158342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of ketamine for intractable cancer pain.
    Lossignol DA; Obiols-Portis M; Body JJ
    Support Care Cancer; 2005 Mar; 13(3):188-93. PubMed ID: 15480820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor.
    Klepstad P; Borchgrevink P; Hval B; Flaat S; Kaasa S
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):616-9. PubMed ID: 11902308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain.
    Fine PG
    J Pain Symptom Manage; 1999 Apr; 17(4):296-300. PubMed ID: 10203883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M; White N; Jean CS; Zempsky WT; Steven K
    J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.
    Mercadante S; Arcuri E; Tirelli W; Casuccio A
    J Pain Symptom Manage; 2000 Oct; 20(4):246-52. PubMed ID: 11027905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-low dose ketamine and memantine treatment for pain in an opioid-tolerant oncology patient.
    Grande LA; O'Donnell BR; Fitzgibbon DR; Terman GW
    Anesth Analg; 2008 Oct; 107(4):1380-3. PubMed ID: 18806055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases.
    Sen S; Aydin ON; Aydin K
    Pain Med; 2006; 7(2):166-9. PubMed ID: 16634730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral ketamine as an adjuvant to oral morphine for neuropathic pain in cancer patients.
    Kannan TR; Saxena A; Bhatnagar S; Barry A
    J Pain Symptom Manage; 2002 Jan; 23(1):60-5. PubMed ID: 11779670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management.
    Lauretti GR; Lima IC; Reis MP; Prado WA; Pereira NL
    Anesthesiology; 1999 Jun; 90(6):1528-33. PubMed ID: 10360847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological findings after long-term infusion of intrathecal ketamine for chronic pain: a case report.
    Stotz M; Oehen HP; Gerber H
    J Pain Symptom Manage; 1999 Sep; 18(3):223-8. PubMed ID: 10517045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects.
    Nesher N; Serovian I; Marouani N; Chazan S; Weinbroum AA
    Pharmacol Res; 2008 Jul; 58(1):38-44. PubMed ID: 18602474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report.
    Julião M; Ulrich J; Calaveiras P; Costa E; Lucas I; Faria de Sousa P
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e902-e907. PubMed ID: 37433626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of extreme tumour pain with morphine and s-ketamine A case report of an 11-year old girl].
    Laufer M; Schippel P; Wild L; Olthoff D
    Schmerz; 2005 Jun; 19(3):220-4. PubMed ID: 15034775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy.
    Lauretti GR; Gomes JM; Reis MP; Pereira NL
    J Clin Anesth; 1999 Dec; 11(8):663-8. PubMed ID: 10680109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance.
    Sator-Katzenschlager S; Deusch E; Maier P; Spacek A; Kress HG
    Anesth Analg; 2001 Oct; 93(4):1032-4, table of contents. PubMed ID: 11574378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.